Here are 1-2 brief analogies for Clarivate (CLVT):

• Bloomberg for scientific and intellectual property intelligence.
• LexisNexis for research publications and patent management.

• Academic & Government Research Solutions: Provides researchers with critical data, analytics, and workflow tools to discover, track, and evaluate research.
• Life Sciences & Healthcare Solutions: Offers intelligence, data, and analytics for drug discovery, clinical development, and commercialization in the pharmaceutical and biotech industries.
• Intellectual Property Solutions: Delivers patent, trademark, and domain intelligence, as well as brand protection and enforcement services.
• Industry Standards & Technical Information: Supplies access to a vast collection of industry standards and technical codes.

Clarivate (CLVT) primarily sells its products and services to other companies and institutions (B2B).

Due to its diversified, subscription-based business model, Clarivate serves tens of thousands of organizations globally. As a result, no single customer or a small group of customers accounts for a material portion of its revenue, and specific major customer companies are not publicly disclosed. Instead, Clarivate's major customers can be identified by the key categories of organizations it serves:

1. Academic and Government Institutions: This category includes universities, research institutions, government agencies, and national libraries worldwide. They are major subscribers to Clarivate's scientific and academic research solutions, such as Web of Science, InCites, and EndNote.
2. Life Sciences and Healthcare Companies: This segment comprises pharmaceutical companies, biotechnology firms, medical device manufacturers, and Contract Research Organizations (CROs). They utilize Clarivate's data and analytics for drug discovery, clinical trials, regulatory intelligence, and commercialization strategies, primarily through solutions like Cortellis.
3. Corporations and Professional Services Firms: This broad category includes law firms, financial institutions, patent offices, and corporate R&D departments across various industries. These customers leverage Clarivate's intellectual property and innovation intelligence solutions, such as Derwent and CPA Global, for patent searching, trademark protection, and IP management.

Jonathan Gear, Chief Executive Officer
Jonathan Gear assumed the role of Chief Executive Officer of Clarivate on September 1, 2022, bringing over two decades of executive leadership experience in technology, data, and information services. Prior to joining Clarivate, Mr. Gear served as the Chief Financial Officer of IHS Markit, where he played a pivotal role in guiding the company through its successful merger with S&P Global. During his 15-year tenure at IHS Markit, he held several senior leadership positions, including President of Resources, Transportation & Consolidated Markets, demonstrating his expertise in driving growth and leading complex business segments. His career also includes leadership roles at Activant Solutions, Inc., smarterwork.com, and Booz Allen Hamilton.

Jonathan Collins, Executive Vice President and Chief Financial Officer
Jonathan Collins joined Clarivate as Executive Vice President and Chief Financial Officer in December 2021. Before his time at Clarivate, Mr. Collins served as Executive Vice President and Chief Financial Officer at Dana Incorporated from March 2016 to December 2021. He also held the position of Senior Vice President and Chief Financial Officer for ProQuest from 2013 to 2016, and Vice President Global Financial Operations at ProQuest from 2010 to 2013.

Gordon Samson, President, Intellectual Property
Gordon Samson was appointed President of Clarivate's Intellectual Property (IP) market segment, effective April 1, 2023. He previously served as Chief Product Officer from February 2022. Mr. Samson joined Clarivate in October 2020 through the acquisition of CPA Global, where he had been Chief Operating Officer since 2014. With over 20 years of experience in senior executive roles, he has a proven track record of driving organizational transformation and growth within the IP industry and beyond.

Jaspal (Jas) Chahal, Chief Legal Officer and General Counsel
Jaspal (Jas) Chahal joined Clarivate as Chief Legal Officer and General Counsel in July 2021. She brings over 25 years of extensive corporate, commercial, and legal experience gained across diverse industries and US-listed information services companies. Ms. Chahal has held various General Counsel roles at organizations such as Brunel University London, IHS Markit, Acxiom Corp, and Sabre Corp.

The rapid advancement and widespread adoption of sophisticated artificial intelligence (AI) and large language models (LLMs) pose a clear emerging threat to Clarivate. Clarivate's core business relies on providing curated data, advanced analytics, and workflow tools for professionals in research, intellectual property, and life sciences. AI and LLMs, particularly when integrated with retrieval-augmented generation (RAG) and other AI techniques, are increasingly capable of:

1. **Automating Information Synthesis and Analysis**: Performing advanced literature reviews, patent landscaping, competitive intelligence, and drug discovery research tasks that traditionally required Clarivate's specialized databases and analytical software.
2. **Disintermediation**: Enabling researchers and professionals to derive insights directly from public, open-access, and semi-public datasets using AI tools, potentially reducing the reliance on Clarivate's proprietary, subscription-based platforms.
3. **Lowering Barriers to Entry**: Allowing new, agile competitors to offer specialized, AI-driven information services at potentially lower costs or with more intuitive interfaces, directly challenging Clarivate's market position.

Clarivate (symbol: CLVT) operates within a global "innovation lifecycle management" market. The total addressable market (TAM) for this sector is estimated to be over $100 billion, with a projected growth rate of 10%.

The company's serviceable addressable market (SAM), which represents the portion of the TAM currently served by Clarivate's solutions, is approximately $25 billion, with an anticipated growth rate of 6%. Clarivate's main products and services cater to three primary segments: Academia & Government, Intellectual Property, and Life Sciences & Healthcare.

Expected Drivers of Future Revenue Growth for Clarivate (CLVT)

Over the next 2-3 years, Clarivate (CLVT) is expected to drive future revenue growth through several key initiatives and market trends:

1. Expansion of Recurring Subscription Revenue and Annual Contract Value (ACV): Clarivate's management has consistently highlighted its commitment to increasing its core subscription and recurring revenue mix. The company has demonstrated sequential and year-over-year improvements in organic Annual Contract Value (ACV) and renewal rates, indicating a focus on expanding its stable, predictable revenue streams.
2. AI-Driven Product Innovation and New Launches: Clarivate is heavily investing in and introducing new AI-powered capabilities and products across its key segments, including Life Sciences & Health and Academia & Government. This strategic focus on artificial intelligence is intended to accelerate organic ACV and recurring revenue growth by enhancing existing offerings and creating new value for customers.
3. Portfolio Optimization and Strategic Disposals: The company is actively rationalizing its solutions portfolio by divesting non-core products and services. While these disposals may lead to short-term revenue adjustments, the long-term goal is to optimize the business model, improve the mix of higher-margin recurring revenue, and drive more sustainable and profitable growth.
4. Growth in Key Market Segments: Clarivate anticipates revenue growth from specific high-potential segments. The company has reported organic ACV growth in its Academia & Government and Life Sciences & Health divisions. Additionally, there has been a notable return to growth in the Intellectual Property segment's patent renewal business, which contributes to recurring revenue.
5. Strategic Price Increases: Price adjustments are contributing to Clarivate's organic ACV growth. The company has indicated that price increases have been a factor in the growth of its annualized contract value.

Share Repurchases

• In May 2023, Clarivate's Board of Directors extended its share repurchase authorization through December 31, 2024, and reduced the authorized amount from $1 billion to $500 million.
• A new share repurchase program of up to $500 million was authorized in December 2024, covering the period from January 1, 2025, through December 31, 2026. This new program replaced the prior one.
• Under the program that terminated on December 31, 2024, Clarivate repurchased $300 million of ordinary shares, including $200 million during the third and fourth quarters of 2024. Through the first nine months of 2025, the company repurchased approximately 34.8 million shares, totaling around $150 million.

Share Issuance

• In June 2024, Clarivate converted its preferred shares into 55.3 million shares of common stock.

Outbound Investments

• Clarivate acquired Decision Resources Group for $950 million in January 2020.
• The company completed the acquisition of CPA Global in October 2020.
• In May 2021, Clarivate acquired ProQuest for $5.3 billion.

Capital Expenditures

• Clarivate's capital expenditures for the last 12 months, as of November 2025, amounted to approximately -$274.70 million.
• Historically, capital expenditures have ranged between 6% and 9% of revenues, with 2023 projected at approximately 9% of revenues.
• The primary focus of capital expenditures has been on capitalized labor, contract services, and other costs associated with product and content development.